Electromagnetic field (EMF) radiation has been found to induce arteriolar dilatation, but the mechanism of action remains largely unknown. This study investigated the effect of EMF radiation on the production of endothelin-1 (ET-1), a potent vasoconstrictor, by cultured endothelial cells. EMF radiation reduced ET-1 basal levels in human umbilical vein and microvascular endothelial cells, but failed to reduce ET-1 basal levels in bovine and human aortic endothelial cells. EMF radiation significantly inhibited thrombin-stimulated ET-1 production in all four endothelial cell types in a dosedependent manner. EMF radiation significantly inhibited thrombin-induced endothelin-1 mRNA expression in all four cell types. The inhibitory effect of EMF radiation on ET-1 production was abolished by the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (10 -3 mol/l). These results demonstrate that EMF radiation modulates ET-1 production in cultured vascular endothelial cells and the inhibitory effect of EMF radiation is, at least partly, mediated through a nitric oxide-related pathway.
Introduction
Irradiation by radio frequency (RF) bursttype electromagnetic fields (EMF) has been reported to induce arteriolar dilatation in the foot web of Xenopus laevis (frog foot web), 1 promote circulatory arterioles in the rabbit ear, 2 and increase the production of nitric oxide and cyclic guanosine monophosphate (GMP) in the rat cerebellum in vitro. 3 These effects have been utilized clinically for alleviating muscular stiffness 4 with a commercially available high-frequency therapeutic device (Matsushita Electric Works Ltd, Osaka, Japan), and the effectiveness of this device for easing lumbar pain has been reported. 5, 6 There is also evidence that EMF promotes bone fracture healing, 7,8 affects the immune system, 9 reduces cell differentiation, 10 and stimulates migration of endothelial cells and capillary repair in culture models. 11 High magnetic flux densities of extremely low frequency EMF are also reported to exert acute effects on leucocyte-endothelium interactions including cell adhesion in vivo. 12 Recently, EMF has been reported to augment angiogenesis primarily by stimulating endothelial release of fibroblast growth factor-β-2, inducing paracrine and autocrine changes in the surrounding tissue. 13 Although the clinical effectiveness of EMF therapy has been observed and the mechanism has been shown to involve radiation-induced nitric oxide synthesis, 3 the biological effects of EMF on the vasculature remain largely unknown.
Endothelin-1 (ET-1), a novel endotheliumderived peptide, has been recognized as a locally produced potent vasoconstrictor. 14 The production of ET-1 is up-regulated by thrombin, transforming growth factor-β1, interleukin-1, tumour necrosis factor-α, adrenaline, apolipoprotein A-I, shearing stress and hypoxia. 15 -17 Its production is down-regulated by nitric oxide, cyclic GMP, prostaglandin E 2 , prostacyclin and atrial natriuretic peptide. 16, 18, 19 ET-1 release from normal human neuronal culture cells is dramatically reduced after exposure (5 min) to a static magnetic field generated by a 0.2 T magnetic resonance tomograph. 20 As a result of these findings, there is considerable interest in whether EMF might improve the local circulation by affecting the production of ET-1.
The present study was performed to investigate the effect of RF burst-type EMF on basal and thrombin-stimulated ET-1 expression and production in cultured endothelial cells from a variety of sources. 
Materials and methods

MATERIALS
CELL CULTURE
Bovine aortic endothelial cells (BAEC) were isolated from bovine aortas according to the previously described method, 21 and grown in DMEM supplemented with 10% fetal bovine serum in 100-mm culture dishes at 37°C in humidified 5% CO 2 . Human umbilical vascular endothelial cells (HUVEC, Lot No. 16197, from a male neonate), human aortic endothelial cells (HAEC, Lot No. 13228, from a female donor aged 58 years old), and human microvascular endothelial cells (HMVEC, Lot No. 14828, from a male neonate) obtained from Sanko Pure Chemical Co. were cultured in EBM-2 medium supplemented with 10% fetal calf serum, 50 µg/ml gentamicin sulphate, 50 µg/ml amphotericin-B, 10 ng/ml epidermal growth factor and 1 mM hydrocortisone under standard conditions 22 at 37°C in humidified 5% CO 2 . Medium was refreshed every 2 days. Cells were passaged at confluence by treatment with 0.05% trypsin/0.02% EDTA in 10 mmol/l phosphate-buffered saline, followed by two washes with medium. BAEC at the fifth to ninth passage and HMVEC and HUVEC at the fourth to sixth passage were used.
ELECTROMAGNETIC FIELD RADIATION SYSTEM
As shown in Fig. 1A , the 96-well culture plate containing endothelial cells was placed on the generator coil. The generator coil of the coil plate consisted of a concentric nine-turn circular loop coil (i.d. 1.2 mm; o.d. 4.4 mm). The distance between the generator coil and the cells was 2.0 mm. When the amplitude of the oscillator (8116A, 50 MHz Pulse/Function Generator HPIB, Hewlett Packard, Telford, UK) was adjusted to 10 and 16 V peak to peak (Vpp), the intensity of the EMF became 1.25 V/m, 0.98 mW/kg and 1.92 V/m, 2.31 mW/kg, respectively. Fig. 1B shows the 100-mm culture dish containing endothelial cells placed on the coil plate. The generator coil of this coil plate consisted of a concentric ten-turn circular loop coil (i.d. 8 mm; o.d. 44 mm). The distance between the generator coil and the cells was 2.3 mm. When the amplitude of the oscillator was adjusted to 16 Vpp, the intensity of the EMF became 3.59 V/m and 8.06 mW/kg. The oscillator was able to emit various patterns of an oscillating burst-type EMF. As shown in Fig. 2 , the frequency was fixed at 10 MHz with a pulse modulation of 10 kHz and 50% burst duty ratio. The EMF applied in the present study was established similarly in type and degree to that in the commercially available device (Matsushita Electric Works Ltd).
DETERMINATION OF ET-1 PRODUCTION
Cells released from confluent stock cultures were seeded into 96-well culture plates at a density of 10 4 cells per well. At confluence, the cells were washed twice with serum-free 547 S Morimoto, T Takahashi, K Shimizu et al. S Morimoto, T Takahashi, K Shimizu et al. Electromagnetic fields inhibit endothelin-1 production medium and then cultured in medium containing 0.1% bovine serum albumin with or without thrombin. The responses of the cells to thrombin at doses of 0.625 -10 U/ml were evaluated in our preliminary experiments. We found that thrombin treatment at 10 U/ml was ideal to investigate the effect of EMF. The cells were incubated with or without irradiation of burst-type EMF as described above for 8 h or 24 h. After incubation, the medium of each well was used to determine ET-1 levels using a sensitive sandwich-enzyme immunoassay as previously described. 23 The cells were then washed twice with 10 mmol/l phosphatebuffered saline, followed by the addition of 0.1 ml of 0.1 mol/l NaOH to dissolve the cells, in order to measure cell protein content by the method of Lowry et al. 24 using bovine serum albumin as a standard. ET-1 content was expressed in nmol/g of cell protein.
Electromagnetic fields inhibit endothelin-1 production
To examine whether nitric oxide may participate in the mediation of ET-1 production by EMF, NG-monomethyl-Larginine (L-NMMA), a competitive inhibitor of nitric oxide synthase, was used to block the synthesis of nitric oxide in endothelial cell cultures. The EMF effects on ET-1 production in cultured endothelial cells were examined during exposure to L-NMMA (10 -3 mol/l).
ANALYSIS OF ET-1 MRNA
For ET-1 mRNA analysis, BAEC released from confluent stock cultures were seeded on 100-mm culture dishes at a density of 5 × 10 4 cells/ml. At confluence, the medium was refreshed with DMEM containing 0.1% bovine serum albumin with or without 10 U/ml thrombin and with or without exposure to EMF radiation (16 Vpp) for 24 h. Total RNA extraction and Northern blot analysis were performed on vascular endothelial cells using 20 µg total RNA/lane, as previously described. 25 The probe used in the studies was a human prepro-ET-1 cDNA (1.17 kb) prepared from the EcoRI site of plasmid pUC18. 26, 27 The membranes were rehybridized with a human glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA probe (1.1 kb) (Clontech Laboratories Inc., Palo Alto, CA, USA). To correct for loading differences, the densitometric signal for each RNA sample hybridized to the ET-1 probe was divided by that hybridized to the GAPDH probe. The size of the ET-1 transcript was estimated from the positions of 28s and 18s ribosomal RNA.
STATISTICAL ANALYSIS
Results are expressed as mean ± SD. Statistical analysis was performed by unpaired Student's t-test. A value of P < 0.05 was considered statistically significant.
Results
EFFECT OF EMF RADIATION ON ET-1 PRODUCTION IN ENDOTHELIAL CELLS
Basal and thrombin-stimulated ET-1 release from BAEC and human endothelial cells increased in a time-dependent manner (Fig. 3A) . Thrombin (10 U/ml) enhanced ET-1 production above the basal levels in BAEC and human endothelial cells (Fig. 3B) . EMF radiation had different effects on the basal secretion of ET-1 in the different endothelial cell types: EMF radiation (16 Vpp) reduced ET-1 basal levels in HUVEC and HMVEC, but failed to reduce endothelin-1 basal levels in BAEC; and EMF radiation enhanced the ET-1 basal level in HAEC (Fig. 4 ). However, EMF radiation significantly inhibited thrombinstimulated ET-1 production in all bovine and human endothelial cell cultures in a dosedependent manner (Fig. 4) . The inhibitory effects of EMF radiation on ET-1 production in each endothelial cell culture were S Morimoto, T Takahashi, K Shimizu et al. Electromagnetic fields inhibit endothelin-1 production abolished in the presence of L-NMMA, an inhibitor of nitric oxide synthase ( Fig. 4 ). Figure 5 shows the time course of endothelin-1 mRNA expression in response to thrombin (10 U/ml) in BAEC, HUVEC, HAEC and HMVEC. Northern blot hybridization showed that the maximal elevations of ET-1 mRNA levels after thrombin treatment were reached after 1 h in all the bovine and human endothelial cells (Fig. 5 ). EMF radiation (16 Vpp) did not affect basal level of ET-1 mRNA, but significantly inhibited thrombinstimulated increase of ET-1 mRNA in all bovine and human endothelial cell cultures (Fig. 6 ).
EFFECT OF EMF RADIATION ON ET-1 MRNA LEVELS IN ENDOTHELIAL CELLS
Discussion
The present study demonstrated that EMF has an inhibitory effect on thrombinstimulated ET-1 production in cultured BAEC and three types of human vascular endothelial cells -HAEC, HMVEC and HUVEC.
The main vascular effects of ET-1 are transient vasodilatation, and profound and sustained vasoconstriction, as well as proliferation of vascular smooth muscle cells. 17 Most of the ET-1 is released abluminally towards the vascular smooth muscle and less is released luminally, and it functions in an autocrine and/or paracrine manner. 17, 28 The synthesis and release of ET-1 is up-regulated by thrombin, 15, 17 16 acidic pH 29 and certain cytokines. 15, 17 The imbalance between ET-1 and other vasoactive substances may therefore be responsible for an alteration of the peripheral vascular resistance under physiological or pathological conditions. We propose that the inhibition of local production of ET-1 in the vasculature by EMF may improve local circulation. Miura et al. 3 have reported that EMF radiation can increase nitric oxide production in rat cerebellum, suggesting a mechanism for EMF-induced vasodilatation. Nitric oxide has been reported to inhibit ET-1 synthesis. 16, 18 Endothelin-1 (nmol/g cell protein)
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Electromagnetic fields inhibit endothelin-1 production
The present study demonstrated that L-NMMA, an inhibitor of nitric oxide synthase, completely abolished the inhibitory effect of EMF on ET-1 production, suggesting that EMF inhibits ET-1 production through a nitric oxide-related pathway. It is reported that thrombin receptor activation increases the release of nitric oxide, 30 raising the possibility that EMF may decrease thrombinmediated ET-1 release through augmented release of nitric oxide. This possibility was confirmed by the observation that the EMF dose-dependent suppression of thrombinstimulated ET-1 release was completely restored by the addition of L-NMMA in all the endothelial cell types studied. On the other hand, the basal production of ET-1 was not inhibited by EMF radiation in BAEC and HAEC cultures, but was inhibited in HMVEC and HUVEC. The reason for the different response to EMF radiation among the three human cell types is unclear. The HMVEC and HUVEC we used were from male neonates, while HAEC were from a female donor aged 58 years old. There is the possibility that the response to EMF radiation is age-or sexrelated, or dependent upon the vascular source of the endothelial cells.
In a previous study, 15 the basal and thrombin-induced ET-1 production in endothelial cells varied according to the site of origin of the cells (microvascular endothelial cells > arterial endothelial cells > venous endothelial cells). In the present study, the basal and thrombin-stimulated ET-1 was highest in the HAEC, followed by HUVEC and HMVEC. The reason why the basal and thrombin-stimulated ET-1 production in our study was different from that in the previous study 15 remains unclear. Despite the different effects of EMF on the basal production of ET-1 among the four endothelial cell types, EMF similarly suppressed the thrombin-induced increase in 
ET-1 production. These observations indicate that EMF might improve the local circulation under the vascular injury by affecting the production of ET-1.
The dose of thrombin used for this study (10 U/ml), which we also used in a previous study, 27 exerted almost maximal responses in ET-1 secretion in all of the bovine and human endothelial cell types. Moreover, the time-course of expression of ET-1 mRNA in the present study was comparable with that of our previous investigation. 27 An interesting observation was the opposite effects of EMF on the basal secretion of ET-1 in different cultured endothelial cell types. EMF radiation substantially enhanced ET-1 secretion in HAEC, but considerably suppressed it in HUVEC. These effects suggest that EMF might reduce the shift of intravascular effusion into the extravascular space. However, EMF was also shown to inhibit the thrombin-induced increase in ET-1 production among every endothelial cell type studied.
In conclusion, the present study demonstrated that EMF radiation modulates endothelin-1 production in cultured vascular endothelial cells and that the inhibitory effect of EMF radiation is mediated through a nitric oxide-related pathway. The modulation of ET-1 production observed in the present study may represent an additional mechanism for the EMF regulation of vascular tone. Whether this mechanism could partly explain the effectiveness of EMF for clinically alleviating muscular stiffness 4 and lumbar pain, 5, 6 however, requires further in vivo research.
